12,841 resources
Start Prev Rows 6400 - 6600 Next
| Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Auth | Source(s) |
|---|---|---|---|---|---|---|---|---|---|
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1.1610 | Referrals Where Weight Assessment May Occur | active | 2023-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1.1751 | Encounter to Evaluate BMI | active | 2024-09 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1.1834 | Encounter to Document Medications | active | 2024-09 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1.1917 | Encounter to Document Medications | active | 2021-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1.695 | Encounter to Evaluate BMI | active | 2025-02 | hl7 | cpt | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1.885 | Encounter to Evaluate BMI | active | 2018-03 | hl7 | cms | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1.886 | Encounter to Evaluate BMI | active | 2023-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1475 | Referral to Primary Care or Alternate Provider | active | 2021-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1476 | Pharmacologic Therapy for Hypertension | active | 2025-02 | hl7 | rx | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1482 | Laboratory Tests for Hypertension | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1497 | Encounter to Screen for Blood Pressure | active | 2024-02 | hl7 | cms | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1508 | Lifestyle Recommendation | active | 2025-01 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1509 | Weight Reduction Recommended | active | 2022-02 | hl7 | cms | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1510 | Weight Reduction Recommended | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1511 | Dietary Recommendations | active | 2025-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1512 | Dietary Recommendations | active | 2025-01 | hl7 | cms | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1514 | Dietary Recommendations | active | 2017-05 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1515 | Dietary Recommendations | active | 2025-02 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1516 | Exercise Class | active | 2017-05 | hl7 | cms | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1518 | Recommendation to Increase Physical Activity | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1537 | Follow Up Within 4 Weeks | active | 2017-05 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1538 | Encounter to Screen for Depression | active | 2025-02 | hl7 | cpt | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1914 | Encounter to Screen for Depression | active | 2020-03 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1915 | Encounter to Screen for Depression | active | 2023-02 | hl7 | cms | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1916 | Encounter to Screen for Depression | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1918 | Encounter to Screen for Blood Pressure | active | 2024-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.192 | Encounter to Screen for Blood Pressure | active | 2025-02 | hl7 | cpt | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.1920 | Encounter to Screen for Blood Pressure | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.2387 | Overweight or Obese | active | 2025-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.2388 | Underweight | active | 2022-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.2395 | Finding of Hypertension | active | 2025-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.2462 | Laboratory Tests for Hypertension | active | 2025-02 | hl7 | loinc | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.2466 | Dental Tooth Extraction | active | 2022-02 | hl7 | |||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.259 | Diagnosis of Hypertension | active | 2025-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.261 | Diagnosis of Hypertension | active | 2021-02 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.263 | Diagnosis of Hypertension | active | 2024-02 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.467 | Follow Up for Adolescent Depression | active | 2024-01 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.468 | Follow Up for Adult Depression | active | 2024-01 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.469 | Adolescent Depression Medications | active | 2023-02 | hl7 | rx | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.470 | Adult Depression Medications | active | 2024-02 | hl7 | rx | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.537 | Referral for Adolescent Depression | active | 2023-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.538 | Referral for Adult Depression | active | 2023-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.791 | Patient Declined | active | 2025-03 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.805 | Weight Reduction Recommended | active | 2022-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.810 | Recommendation to Increase Physical Activity | active | 2017-05 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.600.823 | Referral or Counseling for Alcohol Consumption | active | 2022-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.6366.117 | Absence of Cervix | active | 2024-08 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.666.5.1743 | General or Neuraxial Anesthesia | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.666.5.1940 | Immunocompromised Conditions | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.666.5.2262 | CABG Surgeries | active | 2025-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.666.5.2328 | Immunocompromised Conditions I10 | active | 2022-02 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.666.5.2343 | Immunocompromised Conditions | active | 2024-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.666.5.3011 | Acute Myocardial Infarction | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.666.5.3024 | Acute Myocardial Infarction | active | 2016-03 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.666.5.307 | Encounter Inpatient | active | 2020-03 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.666.5.335 | Bone Marrow Transplant | active | 2021-09 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.666.5.336 | Bone Marrow Transplant | active | 2024-01 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.666.5.404 | Bone Marrow Transplant | active | 2024-02 | hl7 | cms | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.666.5.623 | Acute Myocardial Infarction | active | 2024-02 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.666.5.694 | CABG Surgeries | active | 2024-02 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.666.5.737 | PCI | active | 2018-08 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.666.5.747 | Endotracheal Intubation | active | 2017-05 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.67.1.101.1.128 | Bipolar Disorder | active | 2024-02 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.67.1.101.1.246 | Personality Disorder Emotionally Labile | active | 2024-02 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.67.1.101.1.247 | Personality Disorder Emotionally Labile | active | 2022-02 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.67.1.101.1.248 | Personality Disorder Emotionally Labile | active | 2022-02 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.67.1.101.1.249 | Personality Disorder Emotionally Labile | active | 2023-03 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.67.1.101.1.254 | Dysthymia | active | 2022-02 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.67.1.101.1.256 | Dysthymia | active | 2022-02 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.67.1.101.1.257 | Dysthymia | active | 2023-03 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.67.1.101.1.262 | Deceased | active | 2014-05 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.67.1.101.1.263 | PHQ 9 and PHQ 9M Tools | active | 2022-02 | hl7 | loinc | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.67.1.101.1.269 | Hepatitis B | active | 2017-08 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.67.1.101.1.271 | Hepatitis B | active | 2017-05 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.67.1.101.1.272 | Hepatitis B | active | 2023-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.67.1.101.1.43 | Bipolar Disorder | active | 2022-02 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.67.1.101.1.44 | Bipolar Disorder | active | 2025-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.67.1.101.1.45 | Bipolar Disorder | active | 2022-02 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.67.1.101.11.721 | Deceased | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.67.1.101.11.723 | PHQ-9 Tool | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.6929.2.1000 | Estimated Glomerular Filtration Rate | active | 2024-02 | hl7 | loinc | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.6929.2.1002 | Urine Albumin Creatinine Ratio | active | 2025-03 | hl7 | loinc | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.6929.3.1000 | Estimated Glomerular Filtration Rate | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.6929.3.1007 | Urine Albumin Creatinine Ratio | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.2.1000 | Strabismic Amblyopia | active | 2019-09 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.2.1001 | Strabismic Amblyopia | active | 2019-09 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.2.1002 | Refractive Amblyopia | active | 2019-09 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.2.1003 | Refractive Amblyopia | active | 2019-09 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.2.1004 | Routine Ophthalmological Examination | active | 2019-09 | hl7 | cms | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.2.1005 | Pediatric Best Corrected Visual Acuity Exam | active | 2019-09 | hl7 | loinc | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.2.1006 | LogMAR Visual Acuity Exam | active | 2019-09 | hl7 | loinc | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.2.1007 | Aphakia | active | 2019-09 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.2.1008 | Aphakia | active | 2019-09 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.2.1009 | Infantile and Juvenile Cataract | active | 2019-09 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.2.1010 | Infantile and Juvenile Cataract | active | 2019-09 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.2.1011 | Congenital Corneal or Anterior Segment Conditions | active | 2019-09 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.2.1012 | Congenital Corneal or Anterior Segment Conditions | active | 2019-09 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.2.1013 | Eyelid or Orbital Conditions | active | 2019-09 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.2.1014 | Eyelid or Orbital Conditions | active | 2019-09 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.2.1015 | Coloboma of Optic Disc | active | 2019-09 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.2.1016 | Coloboma of Optic Disc | active | 2019-09 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.2.1017 | Hemorrhage of Optic Nerve Sheath | active | 2019-09 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.2.1018 | Hemorrhage of Optic Nerve Sheath | active | 2019-09 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.2.1019 | Optic Nerve Hypoplasia | active | 2019-09 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.2.1020 | Optic Nerve Hypoplasia | active | 2019-09 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.2.1021 | Disorder of Visual Cortex Due to Underlying Condition | active | 2019-09 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.2.1022 | Disorder of Visual Cortex Due to Underlying Condition | active | 2019-09 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.2.1023 | Cortical Blindness | active | 2019-09 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.2.1024 | Cortical Blindness | active | 2019-09 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.2.1025 | Congenital Condition of Retina | active | 2019-09 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.2.1026 | Congenital Condition of Retina | active | 2019-09 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.3.1000 | Strabismic Amblyopia | active | 2019-09 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.3.1001 | Refractive Amblyopia | active | 2019-09 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.3.1002 | Routine Ophthalmological Examination | active | 2019-09 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.3.1003 | Pediatric Best Corrected Visual Acuity Exam | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.3.1004 | LogMAR Visual Acuity Exam | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.3.1005 | Aphakia | active | 2019-09 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.3.1006 | Infantile and Juvenile Cataract | active | 2019-09 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.3.1007 | Congenital Corneal or Anterior Segment Conditions | active | 2019-09 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.3.1008 | Eyelid or Orbital Conditions | active | 2019-09 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.3.1009 | Coloboma of Optic Disc | active | 2019-09 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.3.1010 | Hemorrhage of Optic Nerve Sheath | active | 2019-09 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.3.1011 | Optic Nerve Hypoplasia | active | 2019-09 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.3.1012 | Disorder of Visual Cortex Due to Underlying Condition | active | 2019-09 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.3.1013 | Cortical Blindness | active | 2019-09 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.8420.3.1014 | Congenital Condition of Retina | active | 2019-09 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.88.12.3221.6.2 | Allergy and Intolerance Type | active | 2024-06 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.88.12.3221.7.2 | Problem Type (SNOMEDCT) | active | 2025-05 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.88.12.3221.8.7 | SPL Drug Route of Administration Terminology | active | 2024-07 | hl7 | ncit | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.88.12.80.62 | Vital Sign Result Type | active | 2024-03 | hl7 | loinc | ||
| us.nlm.vsac | R4 | 2.16.840.1.114222.4.11.3180 | NHSNInsertionSiteCode | active | 2020-06 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.114222.4.11.3181 | NHSNRoleOfPerformerCode | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.114222.4.11.3182 | NHSNReasonForInsertionCode | active | 2020-08 | hl7 | cdc | ||
| us.nlm.vsac | R4 | 2.16.840.1.114222.4.11.3183 | NHSNSkinPreparationCode | active | 2020-08 | hl7 | rx | ||
| us.nlm.vsac | R4 | 2.16.840.1.114222.4.11.3184 | NHSNSterileBarrierCode | active | 2020-08 | hl7 | cdc | ||
| us.nlm.vsac | R4 | 2.16.840.1.114222.4.11.3185 | NHSNCatheterTypeCode | active | 2020-08 | hl7 | cdc | ||
| us.nlm.vsac | R4 | 2.16.840.1.114222.4.11.3194 | NHSNSignificantPathogenCode | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.114222.4.11.3195 | NHSNCriterionOfDiagnosisCode | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.114222.4.11.3196 | NHSNInfectionConditionCode | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.114222.4.11.3234 | NHSNPopulationCategoryCode | active | 2020-08 | hl7 | cdc | ||
| us.nlm.vsac | R4 | 2.16.840.1.114222.4.11.3247 | NHSNTimingCode | active | 2020-08 | hl7 | cdc | ||
| us.nlm.vsac | R4 | 2.16.840.1.114222.4.11.3248 | NHSNEligibilityCode | active | 2020-08 | hl7 | cdc | ||
| us.nlm.vsac | R4 | 2.16.840.1.114222.4.11.3249 | NHSNSpecimenTypeCode | active | 2025-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.114222.4.11.3283 | NHSNOrganismASTCode | active | 2020-06 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.114222.4.11.3360 | NHSNAntimicrobialAgentAURPCode | active | 2025-03 | hl7 | rx | ||
| us.nlm.vsac | R4 | 2.16.840.1.114222.4.11.3361 | NHSNRouteOfAdministrationAURPCode | active | 2020-07 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.114222.4.11.3595 | NHSNPopulationSummaryReportTypeCode | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.114222.4.11.6007 | NHSNVascularAccessTypeCode | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.114222.4.11.6008 | NHSNSuspectedSourceTypeCode | active | 2020-08 | hl7 | cdc | ||
| us.nlm.vsac | R4 | 2.16.840.1.114222.4.11.6042 | NHSNVascularAccessSiteCode | active | 2020-08 | hl7 | cdc | ||
| us.nlm.vsac | R4 | 2.16.840.1.114222.4.11.6051 | NHSNClosureTechniqueCode | active | 2020-08 | hl7 | cdc | ||
| us.nlm.vsac | R4 | 2.16.840.1.114222.4.11.6074 | NHSNStaphAureusTestResults | active | 2020-07 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.114222.4.11.7160 | NHSNStaphAureusSpecificTest | active | 2020-07 | hl7 | loinc | ||
| us.nlm.vsac | R4 | 2.16.840.1.114222.4.11.7214 | NHSNSameDayOutcomeMeasure | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.114222.4.11.7215 | NHSNInfectionFirstReportedSource | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.114222.4.11.7232 | NHSNRaceCategory | active | 2020-06 | hl7 | oid | ||
| us.nlm.vsac | R4 | 2.16.840.1.114222.4.11.7233 | NHSNPreviousPatientLocation | active | 2020-08 | hl7 | cdc | ||
| us.nlm.vsac | R4 | 2.16.840.1.114222.4.11.7237 | NHSNBloodCollectionLocation | active | 2020-08 | hl7 | cdc | ||
| us.nlm.vsac | R4 | 2.16.840.1.114222.4.11.7238 | NHSNPreviousFacility | active | 2020-08 | hl7 | cdc | ||
| us.nlm.vsac | R4 | 2.16.840.1.114222.4.11.7239 | NHSNContraindicationType | active | 2020-08 | hl7 | cdc | ||
| us.nlm.vsac | R4 | 2.16.840.1.114222.4.11.7240 | NHSNCarbaTestMethod | active | 2020-08 | hl7 | cdc | ||
| us.nlm.vsac | R4 | 2.16.840.1.114222.4.11.7241 | NHSNCarbaDetectType | active | 2020-08 | hl7 | cdc | ||
| us.nlm.vsac | R4 | 2.16.840.1.114222.4.11.7242 | NHSNCdiffTestMethod | active | 2020-08 | hl7 | cdc | ||
| us.nlm.vsac | R4 | 2.16.840.1.114222.4.11.7338 | NHSNStartOrContinuation | active | 2020-08 | hl7 | cdc | ||
| us.nlm.vsac | R4 | 2.16.840.1.114222.4.11.7353 | NHSNSummaryBloodProductUsage | active | 2020-08 | hl7 | cdc | ||
| us.nlm.vsac | R4 | 2.16.840.1.114222.4.11.836 | Race | active | 2012-10 | hl7 | oid | ||
| us.nlm.vsac | R4 | 2.16.840.1.114222.4.11.837 | Ethnicity | active | 2012-10 | hl7 | oid | ||
| us.nlm.vsac | R4 | 2.16.840.1.114222.4.11.877 | Detailed Ethnicity | active | 2024-06 | hl7 | oid | ||
| us.nlm.vsac | R4 | 2.16.840.113883.3.67.1.101.3.2444 | Major Depression Including Remission | active | 2021-02 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1222.140 | Ferritin | active | 2024-07 | hl7 | loinc | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.113.12.1005 | Rheumatoid Arthritis | active | 2024-01 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.113.11.1080 | Rheumatoid Arthritis | active | 2021-02 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.113.11.1081 | Rheumatoid Arthritis | active | 2022-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1222.1428 | Myalgia | active | 2024-06 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1222.1439 | Vomiting | active | 2024-07 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1222.1525 | Cognitive disorder Diagnosis ICD10 | active | 2024-06 | hl7 | icd | ||
| hl7.fhir.us.ccda | R4 | 2.16.840.1.113883.11.20.4.1 | DischargeSummaryDocumentTypeCode | trial-use | cgp | 2025-07 | hl7 | loinc | |
| hl7.fhir.us.ccda | R4 | 2.16.840.1.113883.1.11.20.22 | HPDocumentType | trial-use | cgp | 2025-07 | hl7 | loinc | |
| hl7.fhir.us.ccda | R4 | 2.16.840.1.113762.1.4.1099.10 | Care Plan Document Type | trial-use | cgp | 2025-07 | hl7 | loinc | |
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1196.1139 | S4G Hyperlipidemia | active | 2022-08 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1196.1291 | S4G Cardiomyopathy | active | 2022-08 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1196.1292 | S4G Tricuspid valve disorder | active | 2022-08 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1196.1293 | S4G Pompe disease | active | 2022-08 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1196.1294 | S4G Malignant hyperthermia | active | 2022-08 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1196.1295 | S4G Malignancy | active | 2022-08 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1196.1297 | S4G Intestinal polyp | active | 2022-08 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1196.1298 | S4G Hamartoma | active | 2022-08 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1196.1299 | S4G Diabetes mellitus | active | 2022-08 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1196.1300 | S4G Muscular dystrophy and weakness | active | 2022-08 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1196.1325 | S4G Hamartoma and S4G Intestinal Polyp | active | 2022-08 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1196.1326 | S4G Malignancy and S4G Intestinal Polyp | active | 2022-08 | hl7 | vsac | ||
| hl7.fhir.us.registry-protocols | R4 | SmokingStatus | Smoking Status | active | cic | 2023-11 | hl7 | sct | |
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.168 | Cardiac Surgery | active | 2025-02 | hl7 | sct | ||
| fhir.virtually.healthcare | R4 | document-entry-type | DocumentEntry Type | draft | 2025-07 | hl7 | sct | ||
| fhir.nw-gmsa.nhs.uk | R4 | document-entry-type | DocumentEntry Type | draft | 2025-04 | hl7 | sct | ||
| fhir.nw-gmsa.nhs.uk | R4 | GenomicCancer | Genomic Cancer Test Directory | draft | 2025-04 | hl7 | |||
| fhir.nw-gmsa.nhs.uk | R4 | GenomicRareAndInheritedDisease | Genomic Rare and Inherited Disease Test Directory | draft | 2025-04 | hl7 | |||
| fhir.virtually.healthcare | R4 | specialty | Specialty | draft | 2025-07 | hl7 | |||
| fhir.nw-gmsa.nhs.uk | R4 | specialty | Specialty | draft | 2025-04 | hl7 | |||
| fhir.virtually.healthcare | R4 | document-entry-class | DocumentEntry Class | draft | 2025-07 | hl7 | sct |
FHIR